References
- Will RG, Ironside JW, Zeidler M, Estibeiro K, Cousens SN, Smith PG, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 1996;347(9006):921-5.
- Ward HJ, Everington D, Cousens SN, Smith-Bathgate B, Leitch M, Cooper S, et al. Risk factors for variant Creutzfeldt-Jakob disease: a case-control study. Ann Neurol. 2006;59(1):111-20.
- Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science. 1982;216 (4542):136-44. 10.1126/science.6801762
- Knight R, Will RG. Prion diseases. J Neurol Neurosurg Psychiatry. 2004;75(Suppl 1):36-42. 10.1136/jnnp.2004.036137
- Popović M. Prionske bolezni pri človeku. Med Razgl. 1997;36:181–9.
- World Health Organisation. WHO manual for surveillance of human transmissible spongiform encephalopathies including variant Creutzfeldt-Jakob disease, 2003. Accessed January 30th, 2018 at: http://www.who.int/bloodproducts/TSE-manual2003.pdf
- Čakš Jager N. Ocena sistema epidemiološkega spremljanja Creutzfeldt-Jakobove bolezni v Sloveniji: specialistična naloga. Ljubljana: Univerza v Ljubljani, Medicinska fakulteta, 2011.
- European Centre for Disease Prevention and Control (ECDC). Creutzfeldt - Jakob disease International Surveillance Network. CJD Surveillance Data 1993-2013. Accessed January 30th, 2018 at: http://www.eurocjd.ed.ac.uk/surveillance%20data%201.html
- Sikorska B, Knight R, Ironside JW, Liberski PP. Creutzfeldt-Jakob disease. Adv Exp Med Biol. 2012;724:76-90. 10.1007/978-1-4614-0653-2_6
- Collins S, McLean CA, Masters CL. Gerstmann-Sträussler-Scheinker syndrome, fatal familial insomnia, and kuru: a review of these less common human transmissible spongiform encephalopathies. J Clin Neurosci. 2001;8(5):387-97.
- Will RG. Acquired prion disease: iatrogenic CJD, variant CJD, kuru. Br Med Bull. 2003;66(1):255–65. org/10.1093/bmb/66.1.255
- Hsich G, Kenny K, Gibbs CJ, Lee KH, Harrington MG. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med. 1996;335(13):924-30.
- Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, et al. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol. 1998;43(1):32-40.
- Sanchez-Juan P, Sanchez-Valle R, Green A, Ladogana A, Cuadrado-Corrales N, Mitrova E, et al. Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis. J Neurol. 2007;254:901-6.
- Odredba o preventivnih ukrepih v zvezi s transmisivnimi spongiformnimi encefalopatijami. Uradni list RS. 2(12.1.2001):131.
- European Centre for Disease Prevention and Control (ECDC). Facts about variant Creutzfeldt-Jakob disease. Accessed March 3rd, 2018 at: https://ecdc.europa.eu/en/vcjd/facts
- CDC’s Diagnostic Criteria for Creutzfeldt-Jakob Disease (CJD), 2010. Accessed August 30th, 2018 at: https://www.cdc.gov/prions/cjd/diagnostic-criteria.html
- Uprava RS za varno hrano, veterinarstvo in varstvo rastlin. Epidemiološko stanje pri BSE v EU in Sloveniji. Accessed January 30th, 2018 at: http://www.uvhvvr.gov.si/si/delovna_podrocja/tse_transimsivne_spongiformne_encefalopatije/epidemiolosko_stanje_pri_bse_v_eu_in_sloveniji/
- World Health Organisation (WHO). Guidelines on tissue infectivity distribution in transmissible spongiform encephalopathies, 2006. Accessed January 30th, 2018 at: http://www.who.int/bloodproducts/TSEPUBLISHEDREPORT.pdf
- Mitrová E, Belay G. Creutzfeldt-Jakob disease with E200K mutation in Slovakia: characterization and development. Acta Virol. 2002;46(1):31-9.
- Slivarichová D, Mitrová E, Ursínyová M, Uhnáková I, Koscová S, Wsólová L. Geographic accumulation of Creutzfeldt-Jakob disease in Slovakia - environmental metal imbalance as a possible cofactor. Cent Eur J Public Health. 2011;19(3):158-64.
- Meiner Z, Kahana E, Baitcher F, Korczyn AD, Chapman J, Cohen OS, et al. Tau and 14-3-3 of genetic and sporadic Creutzfeldt-Jakob disease patients in Israel. J Neurol. 2011;258(2):255-62. 10.1007/s00415-010-5738-6
- Kojović M, Glavač D, Ožek B, Zupan A, Popović M. De novo P102L mutation in a patient with Gerstmann-Sträussler-Scheinker disease. Eur J Neurol. 2011;18(12):152-3. 10.1111/j.1468-1331.2011.03531.x
- Gubbels S, Bacci S, Laursen H, Hogenhaven H, Cowan S, Molbak K, et al. Description and analysis of 12 years of surveillance for Creutzfeldt–Jakob disease in Denmark, 1997 to 2008. Euro Surveill. 2012;17(15):pii:20142. org/10.2807/ese.17.15.20142-en
- Will RG, Ironside JW, Zeidler M, Estibeiro K, Cousens SN, Smith PG, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 1996;347(9006):921-5.
- Hamlin C, Puoti G, Berri S, Sting E, Harris C, Cohen M, et al. A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease. Neurology. 2012;79(6):547-52. 10.1212/WNL.0b013e318263565f
- The Florey Institute of Neuroscience and Mental Health and The University of Melbourne. Australian national creutzfeldt - jakob disease registry. Accessed January 30th, 2018 at: http://ancjdr.path.unimelb.edu.au/diagnostic-testing/14-3-3-csf-protein-test
- Loftus T, Chen D, Looby S, Chalissery A, Howley R, Heaney C, et al. CJD surveillance in the Republic of Ireland from 2005 to 2015: a suggested algorithm for referrals. Clin Neuropathol. 2017;36(4):188-94. 10.5414/NP301016
- Kustec T, Keše D, Klavs I. Under-reporting of sexually transmitted infection with chlamydia trachomatis - a revision of surveillance system is required. Zdr Varst. 2016;55(3):174-8. 10.1515/sjph-2016-0022
- Budka H, Will RG. The end of the BSE saga: do we still need surveillance for human prion diseases? Swiss Med Wkly. 2015;12(145):w14212. 10.4414/smw.2015.14212